Literature DB >> 33845483

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.

Alexey Stukalov1, Virginie Girault1, Vincent Grass1, Ozge Karayel2, Valter Bergant1, Christian Urban1, Darya A Haas1, Yiqi Huang1, Lila Oubraham1, Anqi Wang1, M Sabri Hamad1, Antonio Piras1, Fynn M Hansen2, Maria C Tanzer2, Igor Paron2, Luca Zinzula3, Thomas Engleitner4, Maria Reinecke5,6,7, Teresa M Lavacca1, Rosina Ehmann8,9, Roman Wölfel8,9, Jörg Jores10, Bernhard Kuster5,6,7, Ulrike Protzer1,9, Roland Rad4, John Ziebuhr11, Volker Thiel12,13, Pietro Scaturro1,14, Matthias Mann2, Andreas Pichlmair15,16.   

Abstract

The emergence and global spread of SARS-CoV-2 has resulted in the urgent need for an in-depth understanding of molecular functions of viral proteins and their interactions with the host proteome. Several individual omics studies have extended our knowledge of COVID-19 pathophysiology1-10. Integration of such datasets to obtain a holistic view of virus-host interactions and to define the pathogenic properties of SARS-CoV-2 is limited by the heterogeneity of the experimental systems. Here we report a concurrent multi-omics study of SARS-CoV-2 and SARS-CoV. Using state-of-the-art proteomics, we profiled the interactomes of both viruses, as well as their influence on the transcriptome, proteome, ubiquitinome and phosphoproteome of a lung-derived human cell line. Projecting these data onto the global network of cellular interactions revealed crosstalk between the perturbations taking place upon infection with SARS-CoV-2 and SARS-CoV at different levels and enabled identification of distinct and common molecular mechanisms of these closely related coronaviruses. The TGF-β pathway, known for its involvement in tissue fibrosis, was specifically dysregulated by SARS-CoV-2 ORF8 and autophagy was specifically dysregulated by SARS-CoV-2 ORF3. The extensive dataset (available at https://covinet.innatelab.org ) highlights many hotspots that could be targeted by existing drugs and may be used to guide rational design of virus- and host-directed therapies, which we exemplify by identifying inhibitors of kinases and matrix metalloproteases with potent antiviral effects against SARS-CoV-2.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33845483     DOI: 10.1038/s41586-021-03493-4

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  72 in total

1.  ERBB receptor activation is required for profibrotic responses to transforming growth factor beta.

Authors:  Mahefatiana Andrianifahanana; Mark C Wilkes; Claire E Repellin; Maryanne Edens; Theodore J Kottom; Rod A Rahimi; Edward B Leof
Journal:  Cancer Res       Date:  2010-09-14       Impact factor: 12.701

2.  Severe acute respiratory syndrome coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signaling.

Authors:  Cromwell T Cornillez-Ty; Lujian Liao; John R Yates; Peter Kuhn; Michael J Buchmeier
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

3.  Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

Authors:  David E Gordon; Joseph Hiatt; Mehdi Bouhaddou; Veronica V Rezelj; Svenja Ulferts; Hannes Braberg; Alexander S Jureka; Kirsten Obernier; Jeffrey Z Guo; Jyoti Batra; Robyn M Kaake; Andrew R Weckstein; Tristan W Owens; Meghna Gupta; Sergei Pourmal; Erron W Titus; Merve Cakir; Margaret Soucheray; Michael McGregor; Zeynep Cakir; Gwendolyn Jang; Matthew J O'Meara; Tia A Tummino; Ziyang Zhang; Helene Foussard; Ajda Rojc; Yuan Zhou; Dmitry Kuchenov; Ruth Hüttenhain; Jiewei Xu; Manon Eckhardt; Danielle L Swaney; Jacqueline M Fabius; Manisha Ummadi; Beril Tutuncuoglu; Ujjwal Rathore; Maya Modak; Paige Haas; Kelsey M Haas; Zun Zar Chi Naing; Ernst H Pulido; Ying Shi; Inigo Barrio-Hernandez; Danish Memon; Eirini Petsalaki; Alistair Dunham; Miguel Correa Marrero; David Burke; Cassandra Koh; Thomas Vallet; Jesus A Silvas; Caleigh M Azumaya; Christian Billesbølle; Axel F Brilot; Melody G Campbell; Amy Diallo; Miles Sasha Dickinson; Devan Diwanji; Nadia Herrera; Nick Hoppe; Huong T Kratochvil; Yanxin Liu; Gregory E Merz; Michelle Moritz; Henry C Nguyen; Carlos Nowotny; Cristina Puchades; Alexandrea N Rizo; Ursula Schulze-Gahmen; Amber M Smith; Ming Sun; Iris D Young; Jianhua Zhao; Daniel Asarnow; Justin Biel; Alisa Bowen; Julian R Braxton; Jen Chen; Cynthia M Chio; Un Seng Chio; Ishan Deshpande; Loan Doan; Bryan Faust; Sebastian Flores; Mingliang Jin; Kate Kim; Victor L Lam; Fei Li; Junrui Li; Yen-Li Li; Yang Li; Xi Liu; Megan Lo; Kyle E Lopez; Arthur A Melo; Frank R Moss; Phuong Nguyen; Joana Paulino; Komal Ishwar Pawar; Jessica K Peters; Thomas H Pospiech; Maliheh Safari; Smriti Sangwan; Kaitlin Schaefer; Paul V Thomas; Aye C Thwin; Raphael Trenker; Eric Tse; Tsz Kin Martin Tsui; Feng Wang; Natalie Whitis; Zanlin Yu; Kaihua Zhang; Yang Zhang; Fengbo Zhou; Daniel Saltzberg; Anthony J Hodder; Amber S Shun-Shion; Daniel M Williams; Kris M White; Romel Rosales; Thomas Kehrer; Lisa Miorin; Elena Moreno; Arvind H Patel; Suzannah Rihn; Mir M Khalid; Albert Vallejo-Gracia; Parinaz Fozouni; Camille R Simoneau; Theodore L Roth; David Wu; Mohd Anisul Karim; Maya Ghoussaini; Ian Dunham; Francesco Berardi; Sebastian Weigang; Maxime Chazal; Jisoo Park; James Logue; Marisa McGrath; Stuart Weston; Robert Haupt; C James Hastie; Matthew Elliott; Fiona Brown; Kerry A Burness; Elaine Reid; Mark Dorward; Clare Johnson; Stuart G Wilkinson; Anna Geyer; Daniel M Giesel; Carla Baillie; Samantha Raggett; Hannah Leech; Rachel Toth; Nicola Goodman; Kathleen C Keough; Abigail L Lind; Reyna J Klesh; Kafi R Hemphill; Jared Carlson-Stevermer; Jennifer Oki; Kevin Holden; Travis Maures; Katherine S Pollard; Andrej Sali; David A Agard; Yifan Cheng; James S Fraser; Adam Frost; Natalia Jura; Tanja Kortemme; Aashish Manglik; Daniel R Southworth; Robert M Stroud; Dario R Alessi; Paul Davies; Matthew B Frieman; Trey Ideker; Carmen Abate; Nolwenn Jouvenet; Georg Kochs; Brian Shoichet; Melanie Ott; Massimo Palmarini; Kevan M Shokat; Adolfo García-Sastre; Jeremy A Rassen; Robert Grosse; Oren S Rosenberg; Kliment A Verba; Christopher F Basler; Marco Vignuzzi; Andrew A Peden; Pedro Beltrao; Nevan J Krogan
Journal:  Science       Date:  2020-10-15       Impact factor: 47.728

4.  Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.

Authors:  Denisa Bojkova; Kevin Klann; Benjamin Koch; Marek Widera; David Krause; Sandra Ciesek; Jindrich Cinatl; Christian Münch
Journal:  Nature       Date:  2020-05-14       Impact factor: 69.504

5.  Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.

Authors:  Christoph B Messner; Vadim Demichev; Daniel Wendisch; Laura Michalick; Matthew White; Anja Freiwald; Kathrin Textoris-Taube; Spyros I Vernardis; Anna-Sophia Egger; Marco Kreidl; Daniela Ludwig; Christiane Kilian; Federica Agostini; Aleksej Zelezniak; Charlotte Thibeault; Moritz Pfeiffer; Stefan Hippenstiel; Andreas Hocke; Christof von Kalle; Archie Campbell; Caroline Hayward; David J Porteous; Riccardo E Marioni; Claudia Langenberg; Kathryn S Lilley; Wolfgang M Kuebler; Michael Mülleder; Christian Drosten; Norbert Suttorp; Martin Witzenrath; Florian Kurth; Leif Erik Sander; Markus Ralser
Journal:  Cell Syst       Date:  2020-06-02       Impact factor: 10.304

6.  Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.

Authors:  Jingjiao Li; Mingquan Guo; Xiaoxu Tian; Xin Wang; Xing Yang; Ping Wu; Chengrong Liu; Zixuan Xiao; Yafei Qu; Yue Yin; Chunxia Wang; Yucai Zhang; Zhaoqin Zhu; Zhenshan Liu; Chao Peng; Tongyu Zhu; Qiming Liang
Journal:  Med (N Y)       Date:  2020-07-21

7.  Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.

Authors:  Daniel Blanco-Melo; Benjamin E Nilsson-Payant; Wen-Chun Liu; Skyler Uhl; Daisy Hoagland; Rasmus Møller; Tristan X Jordan; Kohei Oishi; Maryline Panis; David Sachs; Taia T Wang; Robert E Schwartz; Jean K Lim; Randy A Albrecht; Benjamin R tenOever
Journal:  Cell       Date:  2020-05-15       Impact factor: 41.582

8.  SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.

Authors:  Jessie Huang; Adam J Hume; Kristine M Abo; Rhiannon B Werder; Carlos Villacorta-Martin; Konstantinos-Dionysios Alysandratos; Mary Lou Beermann; Chantelle Simone-Roach; Jonathan Lindstrom-Vautrin; Judith Olejnik; Ellen L Suder; Esther Bullitt; Anne Hinds; Arjun Sharma; Markus Bosmann; Ruobing Wang; Finn Hawkins; Eric J Burks; Mohsan Saeed; Andrew A Wilson; Elke Mühlberger; Darrell N Kotton
Journal:  Cell Stem Cell       Date:  2020-09-18       Impact factor: 24.633

9.  Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication.

Authors:  Kevin Klann; Denisa Bojkova; Georg Tascher; Sandra Ciesek; Christian Münch; Jindrich Cinatl
Journal:  Mol Cell       Date:  2020-08-11       Impact factor: 17.970

10.  A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

Authors:  David E Gordon; Gwendolyn M Jang; Mehdi Bouhaddou; Jiewei Xu; Kirsten Obernier; Kris M White; Matthew J O'Meara; Veronica V Rezelj; Jeffrey Z Guo; Danielle L Swaney; Tia A Tummino; Ruth Hüttenhain; Robyn M Kaake; Alicia L Richards; Beril Tutuncuoglu; Helene Foussard; Jyoti Batra; Kelsey Haas; Maya Modak; Minkyu Kim; Paige Haas; Benjamin J Polacco; Hannes Braberg; Jacqueline M Fabius; Manon Eckhardt; Margaret Soucheray; Melanie J Bennett; Merve Cakir; Michael J McGregor; Qiongyu Li; Bjoern Meyer; Ferdinand Roesch; Thomas Vallet; Alice Mac Kain; Lisa Miorin; Elena Moreno; Zun Zar Chi Naing; Yuan Zhou; Shiming Peng; Ying Shi; Ziyang Zhang; Wenqi Shen; Ilsa T Kirby; James E Melnyk; John S Chorba; Kevin Lou; Shizhong A Dai; Inigo Barrio-Hernandez; Danish Memon; Claudia Hernandez-Armenta; Jiankun Lyu; Christopher J P Mathy; Tina Perica; Kala Bharath Pilla; Sai J Ganesan; Daniel J Saltzberg; Ramachandran Rakesh; Xi Liu; Sara B Rosenthal; Lorenzo Calviello; Srivats Venkataramanan; Jose Liboy-Lugo; Yizhu Lin; Xi-Ping Huang; YongFeng Liu; Stephanie A Wankowicz; Markus Bohn; Maliheh Safari; Fatima S Ugur; Cassandra Koh; Nastaran Sadat Savar; Quang Dinh Tran; Djoshkun Shengjuler; Sabrina J Fletcher; Michael C O'Neal; Yiming Cai; Jason C J Chang; David J Broadhurst; Saker Klippsten; Phillip P Sharp; Nicole A Wenzell; Duygu Kuzuoglu-Ozturk; Hao-Yuan Wang; Raphael Trenker; Janet M Young; Devin A Cavero; Joseph Hiatt; Theodore L Roth; Ujjwal Rathore; Advait Subramanian; Julia Noack; Mathieu Hubert; Robert M Stroud; Alan D Frankel; Oren S Rosenberg; Kliment A Verba; David A Agard; Melanie Ott; Michael Emerman; Natalia Jura; Mark von Zastrow; Eric Verdin; Alan Ashworth; Olivier Schwartz; Christophe d'Enfert; Shaeri Mukherjee; Matt Jacobson; Harmit S Malik; Danica G Fujimori; Trey Ideker; Charles S Craik; Stephen N Floor; James S Fraser; John D Gross; Andrej Sali; Bryan L Roth; Davide Ruggero; Jack Taunton; Tanja Kortemme; Pedro Beltrao; Marco Vignuzzi; Adolfo García-Sastre; Kevan M Shokat; Brian K Shoichet; Nevan J Krogan
Journal:  Nature       Date:  2020-04-30       Impact factor: 69.504

View more
  138 in total

1.  Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs.

Authors:  Caroline Goujon; Antoine Rebendenne; Priyanka Roy; Boris Bonaventure; Ana Chaves Valadao; Lowiese Desmarets; Yves Rouillé; Marine Tauziet; Mary Arnaud-Arnould; Donatella Giovannini; Yenarae Lee; Peter DeWeirdt; Mudra Hegde; Francisco Garcia de Gracia; Joe McKellar; Mélanie Wencker; Jean Dubuisson; Sandrine Belouzard; Olivier Moncorgé; John Doench
Journal:  Res Sq       Date:  2021-05-27

Review 2.  Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19.

Authors:  Jintao Zhang; Chunyuan Zhao; Wei Zhao
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

3.  A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases.

Authors:  Julia Y Wang; Michael W Roehrl; Victor B Roehrl; Michael H Roehrl
Journal:  J Transl Autoimmun       Date:  2022-02-25

4.  Network analytics for drug repurposing in COVID-19.

Authors:  Nicoleta Siminea; Victor Popescu; Jose Angel Sanchez Martin; Daniela Florea; Georgiana Gavril; Ana-Maria Gheorghe; Corina Iţcuş; Krishna Kanhaiya; Octavian Pacioglu; Laura Lona Popa; Romica Trandafir; Maria Iris Tusa; Manuela Sidoroff; Mihaela Păun; Eugen Czeizler; Andrei Păun; Ion Petre
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

5.  Interpretable network propagation with application to expanding the repertoire of human proteins that interact with SARS-CoV-2.

Authors:  Jeffrey N Law; Kyle Akers; Nure Tasnina; Catherine M Della Santina; Shay Deutsch; Meghana Kshirsagar; Judith Klein-Seetharaman; Mark Crovella; Padmavathy Rajagopalan; Simon Kasif; T M Murali
Journal:  Gigascience       Date:  2021-12-29       Impact factor: 6.524

6.  SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation.

Authors:  Bingyu Yan; Tilo Freiwald; Daniel Chauss; Luopin Wang; Erin West; Claudia Kemper; Behdad Afzali; Majid Kazemian; Carmen Mirabelli; Charles J Zhang; Eva-Maria Nichols; Nazish Malik; Richard Gregory; Marcus Bantscheff; Sonja Ghidelli-Disse; Martin Kolev; Tristan Frum; Jason R Spence; Jonathan Z Sexton; Konstantinos D Alysandratos; Darrell N Kotton; Stefania Pittaluga; Jack Bibby; Nathalie Niyonzima; Matthew R Olson; Shahram Kordasti; Didier Portilla; Christiane E Wobus; Arian Laurence; Michail S Lionakis
Journal:  Sci Immunol       Date:  2021-04-07

7.  Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis.

Authors:  Jayanta Kumar Das; Swarup Roy; Pietro Hiram Guzzi
Journal:  Infect Genet Evol       Date:  2021-05-15       Impact factor: 3.342

8.  A scheme for inferring viral-host associations based on codon usage patterns identifies the most affected signaling pathways during COVID-19.

Authors:  Jayanta Kumar Das; Subhadip Chakraborty; Swarup Roy
Journal:  J Biomed Inform       Date:  2021-05-07       Impact factor: 8.000

9.  Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection.

Authors:  Liliana Echavarría-Consuegra; Georgia M Cook; Idoia Busnadiego; Charlotte Lefèvre; Sarah Keep; Katherine Brown; Nicole Doyle; Giulia Dowgier; Krzysztof Franaszek; Nathan A Moore; Stuart G Siddell; Erica Bickerton; Benjamin G Hale; Andrew E Firth; Ian Brierley; Nerea Irigoyen
Journal:  PLoS Pathog       Date:  2021-06-17       Impact factor: 6.823

10.  Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.

Authors:  Shira Weingarten-Gabbay; Susan Klaeger; Siranush Sarkizova; Leah R Pearlman; Da-Yuan Chen; Kathleen M E Gallagher; Matthew R Bauer; Hannah B Taylor; W Augustine Dunn; Christina Tarr; John Sidney; Suzanna Rachimi; Hasahn L Conway; Katelin Katsis; Yuntong Wang; Del Leistritz-Edwards; Melissa R Durkin; Christopher H Tomkins-Tinch; Yaara Finkel; Aharon Nachshon; Matteo Gentili; Keith D Rivera; Isabel P Carulli; Vipheaviny A Chea; Abishek Chandrashekar; Cansu Cimen Bozkus; Mary Carrington; Nina Bhardwaj; Dan H Barouch; Alessandro Sette; Marcela V Maus; Charles M Rice; Karl R Clauser; Derin B Keskin; Daniel C Pregibon; Nir Hacohen; Steven A Carr; Jennifer G Abelin; Mohsan Saeed; Pardis C Sabeti
Journal:  Cell       Date:  2021-06-03       Impact factor: 66.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.